Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 4, 2025COVIDOpen Access

Documenting Clinical Outcomes Assessed in Outpatients with COVID-19: A Scoping Review of Randomized Controlled Trials

View Full Paper
Ask AI
Bookmark
Share

Authors

CKChia Siang KowDRDinesh Sangarran RamachandramBCBarbara R. Conway

Discussion

Loading...

Member takes

Overview

Scoping review documents clinical outcomes in outpatients with COVID-19, highlighting gaps in trial design for key treatments.

Key Points

  • Key outcomes focused on hospitalization rates, symptom resolution, and disease progression in outpatient settings.
  • A total of 91 studies were reviewed from multiple databases, including Web of Science and others, covering various interventions.
  • Common treatments in outpatient trials included hydroxychloroquine, fluvoxamine, convalescent plasma, and ivermectin.
  • The review calls for standardized outcome measures in outpatient COVID-19 trials to enhance trial consistency and relevance.

Cite This Study

Kow et al. (2025) studied this question.

synapsesocial.com/papers/6930e8d7ea1aef094cca3971https://doi.org/10.3390/covid5120199
View Full Paper
Ask AI
Bookmark
Share